THIOREDOXIN SYSTEMS

Thioredoxin Systems AB is a Swedish biomedical company developing a new antibiotic regimen for treating multidrug-resistant infections... Thioredoxin Systems AB was founded in 1994 by Professor Arne Holmgren (1940-2020), former director of the Medical Nobel Institute for Biochemistry at the Karolinska Institute in Sweden. Prof. Holmgren was internationally known as a redox pioneer and the foremost authority in thioredoxin and glutaredoxin studies. His investigations clarified basic sulphur- and selenium-dependent redox mechanisms crucial for DNA synthesis, defence against oxidative stress and redox signalling, in all living cell types from bacteria, plants and mammals. His work remains of particular importance for cancer research and for the understanding and treatment of infectious diseases and inflammation. Prof. Holmgren was a member of the Nobel Assembly at the Karolinska Institutet and of the Royal Swedish Academy of Sciences... Thioredoxin Systems AB is developing an innovative..

Also known as: Thioredoxin Systems AB

Primary location: Solna Sweden